Breaking: CVS Health Q4 earnings arrive above consensus, but guidance sends shares lower
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get all exclusive analysis, access our analysis and get Gold and signals alerts
Elevate your trading Journey.
UPGRADECVS Health reported positive Q4 earnings before the market opened on Wednesday, February 9. Adjusted earnings per share (EPS) of $1.98 beat Wall Street consensus by 5%, and revenue of $76.6 billion beat forecasts by 1.5%.
The retailer confirmed adjusted EPS for the full year ahead of between $8.10 and $8.30 but lowered its guidance on cash flow from operations to between $12 and $13 billion rather than from $12.5 to $13 billion. CVS shares are down 2.6% to $107.93 in Wednesday's premarket.
CVS Health reported positive Q4 earnings before the market opened on Wednesday, February 9. Adjusted earnings per share (EPS) of $1.98 beat Wall Street consensus by 5%, and revenue of $76.6 billion beat forecasts by 1.5%.
The retailer confirmed adjusted EPS for the full year ahead of between $8.10 and $8.30 but lowered its guidance on cash flow from operations to between $12 and $13 billion rather than from $12.5 to $13 billion. CVS shares are down 2.6% to $107.93 in Wednesday's premarket.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.